BFM
BNR

Boothbay Fund Management’s Burning Rock Biotech BNR Stock Holding History

Boothbay Fund Management’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,990
Closed -$44.8K – 2143
2022
Q4 		$44.8K Buy
+1,990
New +$45.4K ﹤0.01% 1881

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boothbay Fund Management's BNR Position: Q1 2023 in Review

Boothbay Fund Management sold out of Burning Rock Biotech (BNR) in Q1 2023, closing a stake of 1,990 shares — an estimated $44.8K sold.

Boothbay Fund Management first reported a position in BNR in Q4 2022 and held it in 1 quarter. The position peaked at $44.8K in Q4 2022. 34 funds tracked by Wall St. Rank hold BNR as of Q1 2023.

  • Boothbay Fund Management reported no remaining Burning Rock Biotech position as of Q1 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 1,990 Burning Rock Biotech shares in Q1 2023, an estimated $44.8K.
  • Boothbay Fund Management first reported a position in Burning Rock Biotech in Q4 2022 and held it in 1 quarter.
  • Boothbay Fund Management's Burning Rock Biotech position peaked at $44.8K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2023.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.